[This article belongs to Volume - 56, Issue - 02, 2024]
Gongcheng Kexue Yu Jishu/Advanced Engineering Science
Journal ID : AES-27-12-2024-44

Title : DESIGN, SYNTHESIS, ANTIPROLIFERATIVE ACTIVITY AND IN SILICO STUDIES OF HYDRAZIDE-HYDRAZONE DERIVATIVE OF ADAMANTANE MOIETY
Dr. Harmeet Kaur Kohli, Dr. Deepa Parab

Abstract :

Objectives: To synthesize a novel adamantane hydrazide hydrazone molecule with potency to function as an effective antiproliferative agent. Method: Novel hydrazide-hydrazone derivative of adamantane moiety containing chloro group (CSAC) was designed and prepared by the condensation of 5-chlorosalicylaldehyde and adamantane-1-carbohydrazide. The structure of this newly synthesised derivative was confirmed by elemental analysis and FTIR, 1H NMR and LC-MS spectroscopy. The MTT-based in vitro cytotoxicity assay for CSAC and another adamantane hydrazide hydrazone derivative 5-NVAC was performed in HeLaPT9 cell line. In Silico analysis was studied to get a better understanding of the compound-target interactions. Findings: When compared with control, CSAC and 5-NVAC showed dose dependent activity after 48h exposure, and showed good toxicity at highest concentration. CSAC and 5-NVAC show good affinity scores against the targeted proteins. The maximum binding affinity score of -8.1 kcal/mole was observed for CSAC against EGFR (PDB ID:3POZ) whereas 5-NVAC showed maximum binding affinity score of -8.7 kcal/mole aginst HER2(PDB ID: 1N8Z). Thus both compounds have potential to show anti-proliferative activity. Conclusion: The compounds CSAC and 5-NVAC have potential to show anti-proliferative activity.